13F Pro Quality Score

61.3/100

Rank #813 of 2,879 stocksTOP 50%

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

61.7/100

Profitability

64.2/100

Balance Sheet

63.7/100

Earnings Quality

49.7/100

Free Cash Flow

52.1/100

Institutional Flow

60.7/100

Revenue Scale

68.0/100

Dilution Risk

59.5/100

ACA Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Arcosa, Inc. (ACA), a Industrials sector company. 13F Pro's AI-powered ranking engine scores ACA at 61.3/100 on a 32-signal composite quality model, placing it at rank #813 of 2,879 stocks — the top half of the AI-ranked universe. Based on the latest XBRL financial filings (Q1 2026), Arcosa, Inc. reports quarterly revenue of $571.7M, net income of $37.8M, an operating margin of 8.2%. Top institutional holders of ACA by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, Neuberger Berman Group, based on the most recent SEC filings. ACA trades on the NYSE exchange and files with the SEC under CIK 1739445. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Arcosa, Inc. directly from SEC EDGAR. Arcosa, Inc.'s 13F Pro composite quality score has ranged between 8 and 67 since 2021, currently 61.3 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q1 2026

$571.7M

Net Income

Q1 2026

$37.8M

Free Cash Flow

Q1 2026

$28.4M

Operating Margin

Q1 2026

8.2%

ROIC

Q1 2026

1.1%

D/E Ratio

Q1 2026

0.57

Get alerted when ACA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Arcosa, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of ACA

Put ACA on your watchlist

Track score changes the day Arcosa, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is ACA a good stock to buy?

13F Pro's AI-powered analysis of Arcosa, Inc. (ACA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACA are available on the ACA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Arcosa, Inc.'s investment landscape.